You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 45 No. 11, November 1988 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

{alpha}-Melanocyte-Stimulating Hormonelike Immunoreactivity Is Increased in Cerebrospinal Fluid of Patients With Parkinson's Disease

Innocenzo Rainero; Jeffrey A. Kaye, MD; Conrad May, MD; Raymon Durso, MD; Douglas I. Katz, MD; Martin L. Albert, MD; Nicola Wolfe, PhD; L. Pinessi, MD; R. P. Friedland, MD; Stanley I. Rapoport, MD

Arch Neurol. 1988;45(11):1224-1227.


Abstract



• We measured {alpha}-melanocyte—stimulating hormonelike immunoreactivity in cerebrospinal fluid of 12 healthy control subjects and nine patients with Parkinson's disease, four of whom had never been treated. Mean cerebrospinal fluid {alpha}-melanocyte—stimulating hormonelike immunoreactivity concentration was twofold greater in parkinsonian patients (44.1 ± 9.3 [SD] pg/mL) as compared with control subjects (21.8 ± 10.0 pg/ mL). No significant correlation was found between cerebrospinal fluid {alpha}-melanocyte—stimulating hormonelike imminoreactivity concentrations and patient age, disease severity, or duration of disease. These results suggest a functional relation between dopaminergic and melanotropinergic systems in the human brain.



Author Affiliations



From the Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda, Md (Drs Rainero, Kaye, May, Pinessi, Friedland, and Rapoport); and the Department of Neurology, Boston University School of Medicine and the Neurology Service, Veterans Administration Medical Center, Boston (Drs Durso, Katz, Albert, and Wolfe). Dr Kaye is currently with the Department of Neurology, University of Oregon Health Sciences, Portland.


Footnotes



Accepted for publication March 21, 1988.

Reprint requests to Laboratory of Neurosciences, National Institute on Aging, Bldg 10, Room 12S207, National Institutes of Health, Bethesda, MD 20892 (Dr Friedland).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.